This activity is supported by an educational grant from GRAIL.
NPs and PAs
Describe the current recommendations for early cancer screening in average-risk, asymptomatic patients and the challenges impacting their uptake
Apply strategies to encourage patients to adhere to cancer screening recommendations
Summarize emerging methodologies for early detection of multiple cancer types
All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Eric Klein, MD: consultant/advisor/speaker: GRAIL.
Beth Sandy, MSN, CRNP: consultant: Amgen, AstraZeneca, Janssen, Jazz, Merck, Takeda.
None of the members of the Planning Committee or staff at PCE and PACE have any relevant financial relationships to disclose, except Beth Sandy, MSN, CRNP as noted above.
Participants wishing to earn CE/CME credit must:
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 67%.
The estimated time to complete this activity is 1.00 hour.
Release date: July 15, 2022
Expiration date: July 14, 2022
eNewsletter with interactive benchmarking and audio commentary
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of PACE or any educational supporter.
Joint Accreditation Statement
In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
NP course advisor: Beth Sandy, MSN, CRNP, Abramson Cancer Center, Philadelphia, Pennsylvania
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
AAPA Credit Designation
Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until July 14, 2023. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Heather Hylton, MS, PA-C, K Health, New York, New York
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This program has been made available online.